Navigation Links
Blackmail Claims Against Harvey Boulter Thrown out of Court
Date:2/23/2012

LONDON, February 23, 2012 /PRNewswire/ --

A United States federal judge in New York has thrown out the case[1] brought by US conglomerate 3M against Harvey Boulter, the CEO of investment fund manager Porton Group, in the latest development in an on-going global legal dispute.

The claims made by 3M that Mr Boulter had attempted to "blackmail" the company were quickly dismissed.

Vindication for Porton Group in New York follows the decision earlier this month of a court in Washington DC to reject all allegations filed there against Mr Boulter by 3M, the manufacturers of Post-it notes.[2]

The closure of the case in New York also comes in the wake of Porton's victory in the High Court in London last November, where 3M was forced to pay damages for breach of its contractual obligations over its failure to develop a test to track MRSA in hospitals after buying the base technology from a consortium led by Porton.

Porton Group CEO, Harvey Boulter, said: "I am delighted we have once again been unequivocally cleared of any misconduct.

"The decisions of the two judges in the US demonstrate that the claims of 3M had absolutely no merit. I am pleased that the case has been closed on this sham of a dispute."    

The decision coincides with the departure of Sir George Buckley as President and CEO of 3M this week (24 February). The legal wrangle was ignited publically when 3M falsely alleged that Mr Boulter had threatened, after a meeting with the then UK Defence Secretary Liam Fox, to use political contacts to have Sir George stripped of his knighthood unless 3M paid Porton $30 million to settle the contract dispute.

Notes to editors:

All inquiries to Eben Black, DLA Piper on +44-7968-559-198 or eben.black@dlapiper.com  or Anna Brown on +44-7834-570-464 or anna.brown@dlapiper.com

1. 3M Company v. Boulter, et al., No. 651708/2011 (Supreme Court of the State of New York, County of New York).

2. 3M Company v. Boulter, et al., No. 11-cv-1527-RLW (U.S. District Court for the District of Columbia).



'/>"/>
SOURCE DLA Piper UK LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Academy of Managed Care Pharmacy (AMCP) Releases Model Audit Guidelines for Pharmacy Claims
2. Pharmacy Franchise Owners Association: Medicine Shoppe International and Medicap Face Claims Filed by Numerous Franchisees
3. Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
4. FDA: Minnesota Companies Agree to Halt Sale of Amino-acid Products with Unapproved Claims
5. MSC CareConnect Provides Real-Time, Online Communication and Referral Management to Claims Professionals
6. Chinmax Disclaims Liability Following China SFDAs Confirmation that Inverness Medical Beijing is Suspected of Forging SFDA Verification Seal and Approval Date in Submission of Triage BNP Test Registration
7. Vinomis Laboratories Launches Vindurance Challenge to Substantiate Claims of Enhanced Physical Endurance with Use of Resveratrol and Quercetin
8. DST Health Solutions iPad® App Helps Improve Efficiency of Claims Administration With Real-Time Alerts
9. New FDLIs Food and Drug Policy Forum Focuses on Liability Issues in Vaccine Design Defect Claims
10. Jury Returns Verdict in VNUS Patent Infringement Lawsuit With Total Vein Systems and biolitec Finding Some Patent Claims Invalid and Some Infringed
11. FDA Warns Three Companies to Stop Making Unproven Claims on Mouth Rinses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
Breaking Medicine News(10 mins):